1. Home
  2. ARCT vs XNET Comparison

ARCT vs XNET Comparison

Compare ARCT & XNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • XNET
  • Stock Information
  • Founded
  • ARCT 2013
  • XNET 2003
  • Country
  • ARCT United States
  • XNET China
  • Employees
  • ARCT N/A
  • XNET N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • XNET Computer Software: Prepackaged Software
  • Sector
  • ARCT Health Care
  • XNET Technology
  • Exchange
  • ARCT Nasdaq
  • XNET Nasdaq
  • Market Cap
  • ARCT 373.7M
  • XNET 373.0M
  • IPO Year
  • ARCT N/A
  • XNET 2014
  • Fundamental
  • Price
  • ARCT $14.94
  • XNET $4.95
  • Analyst Decision
  • ARCT Strong Buy
  • XNET
  • Analyst Count
  • ARCT 8
  • XNET 0
  • Target Price
  • ARCT $52.83
  • XNET N/A
  • AVG Volume (30 Days)
  • ARCT 443.2K
  • XNET 456.6K
  • Earning Date
  • ARCT 08-04-2025
  • XNET 08-12-2025
  • Dividend Yield
  • ARCT N/A
  • XNET N/A
  • EPS Growth
  • ARCT N/A
  • XNET N/A
  • EPS
  • ARCT N/A
  • XNET N/A
  • Revenue
  • ARCT $143,680,000.00
  • XNET $331,614,000.00
  • Revenue This Year
  • ARCT N/A
  • XNET N/A
  • Revenue Next Year
  • ARCT $34.08
  • XNET N/A
  • P/E Ratio
  • ARCT N/A
  • XNET N/A
  • Revenue Growth
  • ARCT 15.38
  • XNET N/A
  • 52 Week Low
  • ARCT $8.04
  • XNET $1.46
  • 52 Week High
  • ARCT $25.88
  • XNET $7.19
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 60.54
  • XNET 55.72
  • Support Level
  • ARCT $12.75
  • XNET $4.35
  • Resistance Level
  • ARCT $15.83
  • XNET $5.10
  • Average True Range (ATR)
  • ARCT 0.86
  • XNET 0.24
  • MACD
  • ARCT 0.12
  • XNET 0.08
  • Stochastic Oscillator
  • ARCT 71.10
  • XNET 80.00

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About XNET Xunlei Limited

Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.

Share on Social Networks: